(Q44604863)

4 December 2017

title

Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth (English)

1 reference

4 December 2017

John G F Cleland

1

1 reference

4 December 2017

Andrew L Clark

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

1234-1237

1 reference

Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Statins and chronic heart failure: do we need a large-scale outcome trial?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Outcome studies with device therapy in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

The heart failure epidemic: exactly how big is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Is the prognosis of heart failure improving?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Is specialty care associated with improved survival of patients with congestive heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Recognising the limits of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Depression and heart failure--not yet a target for therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Heart failure and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Risk stratification in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patien

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

The heart failure revascularisation trial (HEART): rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

Diastolic heart failure: neglected or misdiagnosed?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900948-3

7 January 2021

10.1016/S0735-1097(03)00948-3

Identifiers

DOI

1 reference

4 December 2017

1 reference